Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05319743 · ClinicalTrials.gov registry record
Evaluating Quality and Value of US Ambulatory Care Delivered Among Medicaid Expansion/Non-Expansion States, 2012-2015
A clinical trial of Medicaid Expansion, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 200,000
- Enrollment target
- 1
- Study location
NCT05319743: Completed study of Medicaid Expansion, sponsored by University of California, Los Angeles.
NCT05319743 is a study of Medicaid Expansion that has completed, run by University of California, Los Angeles. The registered enrollment target is 200,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05319743, a study of Medicaid Expansion, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 200,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Quasi-experimental pre-post analysis of the rate of high-value and low-value care services between states that expanded Medicaid and states that did not expand Medicaid January 1, 2014, for adult ambulatory visits, using visit-level survey data from the National Ambulatory Medical Care Survey January 1, 2012 - December 31, 2015.
Primary Outcome
Ex. Numerator = count of high value services provided for adult visits in Medicaid expansion states in 2012/ Denominator = Count of adult visits in Medicaid expansion state in 2012 that had the potential to receive a high value service.
Conditions Studied
Interventions
- OTHER Medicaid Expansion
Study Locations (1)
Michigan
- The University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2022-05-01 |
What the finished NCT05319743 record still lists
NCT05319743 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Medicaid Expansion appearing as the primary indexed condition, and to 1 intervention - of which Medicaid Expansion is the first listed.
NCT05319743 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05319743 about?
NCT05319743 is a clinical study titled "Evaluating Quality and Value of US Ambulatory Care Delivered Among Medicaid Expansion/Non-Expansion States, 2012-2015". Quasi-experimental pre-post analysis of the rate of high-value and low-value care services between states that expanded Medicaid and states that did not expand Medicaid January 1, 2014, for adult ambulatory visits, using visit-level survey data from the National Ambulatory Medical Care Survey Januar...
What is the current status of trial NCT05319743?
This trial is currently completed. The enrollment target is 200,000 participants. The study started on 2021-10-01. Estimated completion is 2022-05-01.
What conditions does trial NCT05319743 study?
This clinical trial studies the following conditions: Medicaid Expansion.
What interventions are being tested in trial NCT05319743?
The interventions under investigation include: Medicaid Expansion (OTHER).
Who is sponsoring clinical trial NCT05319743?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05319743 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI